| # | Drug | Count |
|---|---|---|
| 0 | ZOLEDRONIC ACID | 26 |
| 1 | PAMIDRONATE DISODIUM | 17 |
| 2 | CAPECITABINE | 11 |
| 3 | DEXAMETHASONE | 11 |
| 4 | DEXAMETHASONE 1.5 MG | 11 |
| 5 | THALIDOMIDE | 11 |
| 6 | MELPHALAN | 9 |
| 7 | MELPHALAN HYDROCHLORIDE | 9 |
| 8 | LETROZOLE | 8 |
| 9 | PREDNISONE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PAMIDRONATE DISODIUM | 17 | 0.0050 |
| 1 | LANOLIN, PETROLATUM | 1 | 0.0040 |
| 2 | LANOLIN AND PETROLATUM | 1 | 0.0038 |
| 3 | PLATINUM | 1 | 0.0019 |
| 4 | TAMOXIFEN CITRATE | 7 | 0.0012 |
| 5 | VINORELBINE | 5 | 0.0007 |
| 6 | WHITE PETROLATUM | 1 | 0.0007 |
| 7 | ZOLEDRONIC ACID | 26 | 0.0006 |
| 8 | APOMORPHINE HYDROCHLORIDE | 1 | 0.0006 |
| 9 | MELPHALAN HYDROCHLORIDE | 9 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 17 |
| 1 | Aromatase Inhibitor [EPC] | 16 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 12 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 11 |
| 4 | Benzodiazepine [EPC] | 7 |
| 5 | Loop Diuretic [EPC] | 6 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 6 |
| 7 | HER2/neu Receptor Antagonist [EPC] | 5 |
| 8 | Alkylating Drug [EPC] | 4 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cannabinoid [EPC] | 2 | 0.0002 |
| 1 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 2 | Aromatase Inhibitor [EPC] | 16 | 0.0001 |
| 3 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 4 | Potassium-sparing Diuretic [EPC] | 1 | 0.0001 |
| 5 | Estrogen Receptor Antagonist [EPC] | 3 | 0.0001 |
| 6 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 7 | HER2/neu Receptor Antagonist [EPC] | 5 | 0.0001 |
| 8 | Cholinesterase Inhibitor [EPC] | 1 | 0.0001 |
| 9 | Pyrimidine Synthesis Inhibitor [EPC] | 2 | 0.0000 |